- Home
- Publications
- Publication Search
- Publication Details
Title
Ranibizumab for myopic choroidal neovascularization
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2020-10-02
DOI
10.1080/14712598.2021.1830969
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration
- (2020) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study
- (2020) Robin D. Hamilton et al. PLoS One
- FDA rejects first DARPin
- (2020) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
- (2019) Kaori Sayanagi et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Comparison of intravitreal bevacizumab and ranibizumab used for myopic choroidal neovascularization
- (2019) Qiuming Hu et al. MEDICINE
- Progression and new onset of macular retinoschisis in myopic choroidal neovascularization eyes after Conbercept therapy: a post-hoc analysis
- (2019) Yanping Zhou et al. EYE
- Comparison of Efficacy of Intravitreal Ranibizumab and Aflibercept in Eyes with Myopic Choroidal Neovascularization: 24-Month Follow-Up
- (2019) Andrii Korol et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia
- (2018) Kyoko Ohno-Matsui et al. PROGRESS IN RETINAL AND EYE RESEARCH
- FIVE-YEAR OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA
- (2018) Yuka Onishi et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- RANIBIZUMAB VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY IN ASIAN PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION
- (2018) Youxin Chen et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- CLINICAL OUTCOMES OF INTRAVITREAL BEVACIZUMAB VERSUS PHOTODYNAMIC THERAPY WITH OR WITHOUT BEVACIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION
- (2017) Eui Chun Kang et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- FIVE-YEAR OUTCOMES OF INTRAVITREAL INJECTION OF RANIBIZUMAB FOR THE TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION
- (2017) Tsung-Tien Wu et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- SIX-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA
- (2017) Kaori Kasahara et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- LONG-TERM OUTCOMES OF RANIBIZUMAB TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION IN EAST-ASIAN PATIENTS FROM THE RADIANCE STUDY
- (2017) Nikolle W. Tan et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- EFFICACY AND SAFETY OF RANIBIZUMAB FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION DUE TO UNCOMMON CAUSE
- (2017) Timothy Y. Y. Lai et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Ranibizumab in Myopic Choroidal Neovascularization: A Subgroup Analysis by Ethnicity, Age, and Ocular Characteristics in RADIANCE
- (2016) Frank G. Holz et al. OPHTHALMOLOGICA
- MYOPIC CHOROIDAL NEOVASCULARIZATION
- (2016) Timothy Y. Y. Lai et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- International Photographic Classification and Grading System for Myopic Maculopathy
- (2015) Kyoko Ohno-Matsui et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Effect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisation
- (2015) Ciro Costagliola et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization
- (2015) Yasushi Ikuno et al. OPHTHALMOLOGY
- Myopic choroidal neovascularisation: current concepts and update on clinical management
- (2014) Tien Y Wong et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Ranibizumab, Verteporfin Photodynamic Therapy or Observation for the Treatment of Myopic Choroidal Neovascularization: Cost Effectiveness in the UK
- (2014) Lindsay Claxton et al. DRUGS & AGING
- Oxygen sensing and metabolic homeostasis
- (2014) Biff F. Palmer et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Epidemiology and Disease Burden of Pathologic Myopia and Myopic Choroidal Neovascularization: An Evidence-Based Systematic Review
- (2013) Tien Y. Wong et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study
- (2013) A Tufail et al. EYE
- Ranibizumab in Myopic Choroidal Neovascularization: The 12-Month Results from the REPAIR Study
- (2013) Adnan Tufail et al. OPHTHALMOLOGY
- RADIANCE: A Randomized Controlled Study of Ranibizumab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia
- (2013) Sebastian Wolf et al. OPHTHALMOLOGY
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization
- (2012) T Y Y Lai et al. EYE
- Choroidal neovascularization in pathological myopia
- (2012) Kumari Neelam et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Anti–Vascular Endothelial Growth Factor Therapy for Myopic Choroidal Neovascularization
- (2012) Timothy Y. Y. Lai RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- LONG-TERM RESULTS OF PHOTODYNAMIC THERAPY FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION WITH PATHOLOGIC MYOPIA
- (2012) Fabrizio Giansanti et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INTRAVITREAL RANIBIZUMAB VERSUS BEVACIZUMAB FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION
- (2012) Pierluigi Iacono et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab
- (2011) C H Meyer et al. EYE
- Laser Photocoagulation, Photodynamic Therapy, and Intravitreal Bevacizumab for the Treatment of Juxtafoveal Choroidal Neovascularization Secondary to Pathologic Myopia
- (2010) Maurizio Battaglia Parodi ARCHIVES OF OPHTHALMOLOGY
- Therapeutic monoclonal antibodies in ophthalmology
- (2008) Eduardo B. Rodrigues et al. PROGRESS IN RETINAL AND EYE RESEARCH
- CHANGES IN AQUEOUS VASCULAR ENDOTHELIAL GROWTH FACTOR AND PIGMENT EPITHELIAL-DERIVED FACTOR LEVELS FOLLOWING INTRAVITREAL BEVACIZUMAB INJECTIONS FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION OR PATHOLOGIC MYOPIA
- (2008) WAI-MAN CHAN et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Choroidal Neovascularization in Pathologic Myopia: Recent Developments in Diagnosis and Treatment
- (2008) Gisèle Soubrane SURVEY OF OPHTHALMOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started